PACB logo

Pacific Biosciences Of California (PACB) Depreciation And Amortization

Annual D&A

$26.53 M
+$9.22 M+53.22%

31 December 2023

1-Year Change

+53.22%
PACB annual depreciation & amortization is up +53.22% year-on-year

3-Year Change

+185.19%
PACB annual depreciation & amortization is up +185.19% over the past 3 years

All-time High

$26.53 M
PACB annual depreciation & amortization is currently at an all-time high

Sector Rank

80.98%
PACB annual depreciation & amortization is higher than 80.98% of companies in Healthcare sector
Annual Total Expenses$510.89 M
PACB annual total expenses is $510.89 million
Annual Operating Expenses$363.14 M
PACB annual total operating expenses is $363.14 million
Annual Revenue$200.52 M
PACB annual revenue is $200.52 million
Annual Net Income-$306.74 M
PACB annual net profit is -$306.74 million

PACB Depreciation And Amortization Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly D&A

$16.10 M
+$1.81 M+12.67%

30 September 2024

1-Year Change

+195.12%
PACB quarterly depreciation & amortization is up +195.12% year-on-year

3-Year Change

+493.84%
PACB quarterly depreciation & amortization is up +493.84% over the past 3 years

All-time High

$16.10 M
PACB quarterly depreciation & amortization is currently at an all-time high

Sector Rank

86.27%
PACB quarterly depreciation & amortization is higher than 86.27% of companies in Healthcare sector
Quarterly Total Expenses$102.87 M
PACB quarterly total expenses is $102.87 million
Quarterly Operating Expenses$72.91 M
PACB quarterly total operating expenses is $72.91 million
Quarterly Revenue$39.97 M
PACB quarterly revenue is $39.97 million
Quarterly Net Income-$60.73 M
PACB quarterly net profit is -$60.73 million

PACB Quarterly D&A Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

TTM D&A

$54.10 M
+$10.64 M+24.49%

30 September 2024

1-Year Change

+179.17%
PACB TTM depreciation & amortization is up +179.17% year-on-year

3-Year Change

+449.25%
PACB TTM depreciation & amortization is up +449.25% over the past 3 years

All-time High

$54.10 M
PACB TTM depreciation & amortization is currently at an all-time high

Sector Rank

85.06%
PACB TTM depreciation & amortization is higher than 85.06% of companies in Healthcare sector
Annual Total Expenses$510.89 M
PACB annual total expenses is $510.89 million
Annual Operating Expenses$363.14 M
PACB annual total operating expenses is $363.14 million
TTM Revenue$173.15 M
PACB TTM revenue is $173.15 million
TTM Net Income-$394.24 M
PACB TTM net profit is -$394.24 million

PACB TTM D&A Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PACB Depreciation And Amortization Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+53.2%+195.1%+179.2%
3 y3 years+185.2%+493.8%+449.3%
5 y5 years+267.8%+528.4%+487.0%

PACB Depreciation And Amortization High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3 yearsat high+185.2%at high+493.8%at high+449.3%
5 y5 yearsat high+267.8%at high+608.6%at high+487.0%
alltimeall timeat high+1582.6%at high+1798.5%at high+5047.6%

Pacific Biosciences Of California Depreciation And Amortization History

DateAnnualQuarterlyTTM
Sept 2024
-
$16.10 M(+12.7%)
$54.10 M(+24.5%)
June 2024
-
$14.29 M(+18.9%)
$43.46 M(+27.7%)
Mar 2024
-
$12.01 M(+2.7%)
$34.03 M(+28.3%)
Dec 2023
$26.53 M(+53.2%)
$11.70 M(+114.5%)
$26.53 M(+36.9%)
Sept 2023
-
$5.46 M(+12.2%)
$19.38 M(+6.3%)
June 2023
-
$4.86 M(+7.7%)
$18.24 M(+3.4%)
Mar 2023
-
$4.52 M(-0.6%)
$17.64 M(+1.9%)
Dec 2022
$17.32 M(+49.5%)
$4.54 M(+5.3%)
$17.32 M(+2.7%)
Sept 2022
-
$4.32 M(+1.1%)
$16.86 M(+10.5%)
June 2022
-
$4.27 M(+1.8%)
$15.26 M(+14.0%)
Mar 2022
-
$4.19 M(+2.6%)
$13.38 M(+15.5%)
Dec 2021
$11.59 M(+24.5%)
$4.08 M(+50.7%)
$11.59 M(+17.6%)
Sept 2021
-
$2.71 M(+13.3%)
$9.85 M(+4.2%)
June 2021
-
$2.39 M(-0.1%)
$9.46 M(+1.3%)
Mar 2021
-
$2.40 M(+2.0%)
$9.33 M(+0.3%)
Dec 2020
$9.30 M(-6.5%)
$2.35 M(+1.5%)
$9.30 M(-1.7%)
Sept 2020
-
$2.32 M(+1.9%)
$9.46 M(-2.5%)
June 2020
-
$2.27 M(-4.0%)
$9.71 M(-1.6%)
Mar 2020
-
$2.37 M(-5.8%)
$9.87 M(-0.8%)
Dec 2019
$9.95 M(+37.9%)
$2.51 M(-2.0%)
$9.95 M(+7.9%)
Sept 2019
-
$2.56 M(+5.6%)
$9.22 M(+8.7%)
June 2019
-
$2.43 M(-0.9%)
$8.48 M(+7.8%)
Mar 2019
-
$2.45 M(+37.7%)
$7.86 M(+9.0%)
Dec 2018
$7.21 M(-14.5%)
$1.78 M(-2.5%)
$7.21 M(-0.4%)
Sept 2018
-
$1.82 M(+0.9%)
$7.25 M(+0.4%)
June 2018
-
$1.81 M(+0.4%)
$7.21 M(-2.4%)
Mar 2018
-
$1.80 M(-0.4%)
$7.39 M(-12.4%)
Dec 2017
$8.44 M(+117.9%)
$1.81 M(+0.9%)
$8.44 M(+9.9%)
Sept 2017
-
$1.79 M(-9.9%)
$7.68 M(+11.5%)
June 2017
-
$1.99 M(-30.2%)
$6.89 M(+17.3%)
Mar 2017
-
$2.85 M(+170.7%)
$5.88 M(+51.7%)
DateAnnualQuarterlyTTM
Dec 2016
$3.88 M(+5.4%)
$1.05 M(+5.4%)
$3.88 M(+1.8%)
Sept 2016
-
$999.00 K(+2.5%)
$3.81 M(+4.1%)
June 2016
-
$975.00 K(+15.0%)
$3.65 M(+1.0%)
Mar 2016
-
$848.00 K(-13.7%)
$3.62 M(-1.6%)
Dec 2015
$3.68 M(-12.9%)
$983.00 K(+15.9%)
$3.68 M(+2.0%)
Sept 2015
-
$848.00 K(-9.6%)
$3.60 M(-4.0%)
June 2015
-
$938.00 K(+3.3%)
$3.76 M(-3.9%)
Mar 2015
-
$908.00 K(-0.2%)
$3.91 M(-7.4%)
Dec 2014
$4.22 M(-25.3%)
$910.00 K(-9.0%)
$4.22 M(-10.6%)
Sept 2014
-
$1.00 M(-8.3%)
$4.72 M(-6.7%)
June 2014
-
$1.09 M(-10.7%)
$5.06 M(-5.8%)
Mar 2014
-
$1.22 M(-13.4%)
$5.38 M(-4.8%)
Dec 2013
$5.65 M(-15.1%)
$1.41 M(+5.1%)
$5.65 M(-3.4%)
Sept 2013
-
$1.34 M(-4.5%)
$5.85 M(-5.6%)
June 2013
-
$1.40 M(-6.0%)
$6.19 M(-4.9%)
Mar 2013
-
$1.49 M(-7.2%)
$6.51 M(-2.0%)
Dec 2012
$6.65 M(+14.6%)
$1.61 M(-4.7%)
$6.65 M(+1.5%)
Sept 2012
-
$1.69 M(-2.1%)
$6.55 M(+3.9%)
June 2012
-
$1.72 M(+5.8%)
$6.30 M(+5.7%)
Mar 2012
-
$1.63 M(+8.1%)
$5.96 M(+2.8%)
Dec 2011
$5.80 M(+12.5%)
$1.51 M(+4.6%)
$5.80 M(+0.9%)
Sept 2011
-
$1.44 M(+3.9%)
$5.75 M(-0.0%)
June 2011
-
$1.39 M(-5.5%)
$5.75 M(+3.2%)
Mar 2011
-
$1.47 M(+0.8%)
$5.58 M(+8.1%)
Dec 2010
$5.16 M(+25.7%)
$1.46 M(+1.0%)
$5.16 M(+39.3%)
Sept 2010
-
$1.44 M(+19.4%)
$3.70 M(+63.8%)
June 2010
-
$1.21 M(+15.0%)
$2.26 M(+115.0%)
Mar 2010
-
$1.05 M
$1.05 M
Dec 2009
$4.10 M(+37.4%)
-
-
Dec 2008
$2.99 M(+89.4%)
-
-
Dec 2007
$1.58 M
-
-

FAQ

  • What is Pacific Biosciences of California annual depreciation & amortization?
  • What is the all time high annual D&A for Pacific Biosciences of California?
  • What is Pacific Biosciences of California annual D&A year-on-year change?
  • What is Pacific Biosciences of California quarterly depreciation & amortization?
  • What is the all time high quarterly D&A for Pacific Biosciences of California?
  • What is Pacific Biosciences of California quarterly D&A year-on-year change?
  • What is Pacific Biosciences of California TTM depreciation & amortization?
  • What is the all time high TTM D&A for Pacific Biosciences of California?
  • What is Pacific Biosciences of California TTM D&A year-on-year change?

What is Pacific Biosciences of California annual depreciation & amortization?

The current annual D&A of PACB is $26.53 M

What is the all time high annual D&A for Pacific Biosciences of California?

Pacific Biosciences of California all-time high annual depreciation & amortization is $26.53 M

What is Pacific Biosciences of California annual D&A year-on-year change?

Over the past year, PACB annual depreciation & amortization has changed by +$9.22 M (+53.22%)

What is Pacific Biosciences of California quarterly depreciation & amortization?

The current quarterly D&A of PACB is $16.10 M

What is the all time high quarterly D&A for Pacific Biosciences of California?

Pacific Biosciences of California all-time high quarterly depreciation & amortization is $16.10 M

What is Pacific Biosciences of California quarterly D&A year-on-year change?

Over the past year, PACB quarterly depreciation & amortization has changed by +$10.64 M (+195.12%)

What is Pacific Biosciences of California TTM depreciation & amortization?

The current TTM D&A of PACB is $54.10 M

What is the all time high TTM D&A for Pacific Biosciences of California?

Pacific Biosciences of California all-time high TTM depreciation & amortization is $54.10 M

What is Pacific Biosciences of California TTM D&A year-on-year change?

Over the past year, PACB TTM depreciation & amortization has changed by +$34.72 M (+179.17%)